Triple threat: radiation, chemo, and immunotherapy before surgery shows promise in advanced oral cancer trial
NCT ID NCT07402538
First seen Feb 13, 2026 · Last updated May 08, 2026 · Updated 13 times
Summary
This study tests whether giving a short course of targeted radiation (SBRT) along with chemotherapy and immunotherapy before surgery can help people with advanced mouth or throat cancer live longer without the cancer coming back. About 184 adults with untreated, advanced oral or HPV-negative throat cancer will take part. The goal is to see if this combination improves event-free survival at two years compared to standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.